Simplify Logo

Full-Time

Associate Director

Manufacturing

Confirmed live in the last 24 hours

Beam Therapeutics

Beam Therapeutics

201-500 employees

Develops precision genetic medicines using base editing

Biotechnology
Healthcare

Senior

Durham, NC, USA

Category
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • Knowledge of science attained through studies resulting in a B.S. in science, engineering, biochemistry or related discipline, or its equivalent is preferred with 12 + years of relevant experience in a GMP environment
  • Knowledge of aseptic processing/cell culture/cell and gene therapy manufacturing, analytical testing is strongly preferred.
  • Must be willing to have a flexible schedule to support a multi-shift operation that covers nights and weekends as needed.
  • Must have experience in drafting and reviewing technical documents with high technical writing skill.
  • Working knowledge of validation and related concepts.
  • Travel for in-person interactions with cross-functional stakeholders to ensure tech transfer is on track as needed.
  • Able to independently troubleshoot problems and issues; called upon to train or assist others for a large portion of the job.
  • Proficient in Microsoft Word, Excel, Power Point, and other applications. Preferred knowledge of Veeva QMS.
  • Good listening and communication skills.
  • Positive approach and highly collaborative persona.
Responsibilities
  • Supervise, organize, coach, develop a small team of Manufacturing Specialists and SMEs (subject matter experts). Work in parallel on any compliance related activities as an author, contributor as needed.
  • Provide support for all related start up and continuous production activities related to operational readiness including, but not limited to procedure creation, equipment qualification and validation
  • Participate as manufacturing representative on all new product introduction or tech transfer projects
  • Initiate and drive to completion deviations, change controls and CAPAs for appropriateness, completeness and to meet internal procedures and regulatory expectations.
  • Work collaboratively with cross functional teams, partners, and vendors to gather background knowledge needed to complete assignments.
  • Provides manufacturing and operational guidance and recommendations in a professional and collaborative manner to internal and external stakeholders.
  • Drafts and reviews SOPs (Standard Operating Procedure) and related GMP documents as needed.
  • Provide operational support and guidance as needed to contract manufacturing operations (attend meetings, person in plant review and approval of CMO (Contract Manufacturing Organization) documentation.)
  • Monitors and trends batch record errors, provides management with quality indicator data, and collaborates with stakeholders to reduce sources of error.
  • Applies strong technical expertise of MFG/QA processes to support development and maintenance of cGMP compliant quality performance.
  • Provides consistently prompt, efficient, dependable, highly skilled service.
  • Demonstrates consistent judgment, quality, accuracy, speed, and creativity.
  • Detects and resolves problems; assists others with problem resolution; misjudgment may jeopardize compliance.
  • Understands, selects, and uses appropriate risk management and root cause analysis tools.
  • Takes initiative in making improvement suggestions to promote operational goals.
  • Applies Quality concepts and company policies to resolve issues of moderate complexity in an effective manner.
  • Reflects solid understanding of strategies and goals and can take part in major parts of projects or provide expert service.
  • Recommends improvements to on-going processes and projects.
  • Facilitates designing processes with Quality built in from the beginning.
  • Identifies and uses good judgement to handle out-of-compliance situations.

Beam Therapeutics develops precision genetic medicines using a technique called base editing, which allows for precise modifications to the genetic code to potentially correct mutations that lead to serious diseases. Their primary focus is on treating genetic disorders, such as sickle cell disease, with the aim of providing lifelong cures instead of temporary solutions. The company invests significantly in research and development to create new therapies and generates revenue through partnerships, licensing agreements, and future commercialization of their treatments. Unlike many competitors, Beam Therapeutics emphasizes collaboration with pharmaceutical companies and research institutions, which helps them secure funding and advance their projects. Their goal is to advance scientific research and deliver effective, long-lasting treatments for patients.

Company Stage

IPO

Total Funding

$689M

Headquarters

Cambridge, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

4%

1 year growth

-8%

2 year growth

-7%
Simplify Jobs

Simplify's Take

What believers are saying

  • Beam Therapeutics' innovative base editing technology has the potential to revolutionize the treatment of genetic disorders, offering hope for lifelong cures.
  • The company's strong pipeline, including early-stage studies for sickle cell disease, positions it well for future growth and breakthroughs.
  • Significant investments and partnerships, like the recent $250 million deal with Eli Lilly, enhance Beam's financial stability and research capabilities.

What critics are saying

  • The recent retirement of CFO Terry-Ann Burrell and the layoff of 20% of staff could lead to operational disruptions and affect company morale.
  • Beam's focus on early-stage studies means that its treatments are still years away from commercialization, posing a risk to short-term revenue generation.

What makes Beam Therapeutics unique

  • Beam Therapeutics leverages base editing technology, which allows for precise genetic modifications, setting it apart from traditional gene-editing methods like CRISPR.
  • The company's focus on developing lifelong cures for genetic disorders, rather than temporary treatments, distinguishes it in the biotechnology sector.
  • Beam's strategic partnerships and licensing agreements, such as the $250 million deal with Eli Lilly, provide significant financial backing and collaborative opportunities.

Help us improve and share your feedback! Did you find this helpful?